Meta-analysis
Open access
Aug 2026
Efficacy and safety of immunotherapy in driver mutation-negative advanced non-small cell lung cancer: A systematic review and meta-analysis
Immunotherapy, whether administered alone or in combination with chemotherapy, provides significant survival benefits in patients with advanced driver mutation–negative NSCLC, and is evaluated using the GRADE framework.
J. Kumar, S. Ganguly, P. Kaur et al.
· The Indian journal of medica... · 0 citations